Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes
Renecia A Watkins, Carmella Evans-Molina, Jennifer K Terrell, Kathleen H Day, Lynette Guindon, Ivan A Restrepo, Raghavendra G Mirmira, Janice S Blum, Linda A DiMeglio, Renecia A Watkins, Carmella Evans-Molina, Jennifer K Terrell, Kathleen H Day, Lynette Guindon, Ivan A Restrepo, Raghavendra G Mirmira, Janice S Blum, Linda A DiMeglio
Abstract
Rapid evaluation of therapies designed to preserve β cells in persons with type 1 diabetes (T1D) is hampered by limited availability of sensitive β-cell health biomarkers. In particular, biomarkers elucidating the presence and degree of β-cell stress are needed. We characterized β-cell secretory activity and stress in 29 new-onset T1D subjects (10.6 ± 3.0 years, 55% male) at diagnosis and then 8.2 ± 1.2 weeks later at first clinic follow-up. We did comparisons with 16 matched healthy controls. We evaluated hemoglobin A1c (HbA1c), β-cell function (random C-peptide [C] and proinsulin [PI]), β-cell stress (PI:C ratio), and the β-cell stress marker heat shock protein (HSP)90 and examined these parameters' relationships with clinical and laboratory characteristics at diagnosis. Mean diagnosis HbA1c was 11.3% (100 mmol/mol) and 7.6% (60 mmol/mol) at follow-up. C-peptide was low at diagnosis (P < 0.001 vs controls) and increased at follow-up (P < 0.001) to comparable with controls. PI did not differ from controls at diagnosis but increased at follow-up (P = 0.003) signifying increased release of PI alongside improved insulin secretion. PI:C ratios and HSP90 concentrations were elevated at both time points. Younger subjects had lower C-peptide and greater PI, PI:C, and HSP90. We also examined islets isolated from prediabetic nonobese diabetic mice and found that HSP90 levels were increased ∼4-fold compared with those in islets isolated from matched CD1 controls, further substantiating HSP90 as a marker of β-cell stress in T1D. Our data indicate that β-cell stress can be assessed using PI:C and HSP90. This stress persists after T1D diagnosis. Therapeutic approaches to reduce β-cell stress in new-onset T1D should be considered.
Conflict of interest statement
Conflicts of Interest: No authors on this article have a conflict of interest that is relevant to the subject matter or materials included in this work. No authors on this article have financial or personal relationships to disclose with organizations that could potentially be perceived as influencing the described research. All authors have read the journal’s policy on conflicts of interest and the journal’s authorship agreement.
Copyright © 2016 Elsevier Inc. All rights reserved.
Figures
Source: PubMed